β2-Microglobulin increases the expression of vascular cell adhesion molecule on human synovial fibroblasts

M. I. Jaradat, C. T. Schnizlein-Bick, G. K. Singh, Sharon Moe

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background. β2-Microglobulin (β2m) amyloidosis is a destructive articular disease that affects patients on dialysis. The disease presentation is similar to other forms of arthritis in which adhesion molecules are felt to be pathogenic. Therefore, we hypothesized that β2m directly increases the expression of vascular cell adhesion molecule-1 (VCAM-1) by synovial fibroblasts. We also examined the effect of alteration of β2m by advanced glycation end products on this cellular response. Methods. Human synovial fibroblasts were isolated and incubated with β2m with and without alteration with advanced glycation end products. VCAM-1 expression was determined by immunohistochemistry, flow cytometry, and Western blot and Northern blot analyses. Results. β2m increased the protein expression of VCAM-1 by synovial fibroblasts in a dose-dependent manner. β2m altered with advanced glycation end products had no effect. However, all forms of β2m increased VCAM-1 mRNA. β2m also increased the adhesion of peripheral blood mononuclear cells to synovial fibroblasts. Conclusion. β2m directly increases the expression of VCAM-1 by synovial fibroblasts, indicating that synovial fibroblasts may play a key role in the pathogenesis of β2m amyloidosis.

Original languageEnglish
Pages (from-to)1951-1959
Number of pages9
JournalKidney International
Volume59
Issue number5
DOIs
StatePublished - 2001

Fingerprint

Vascular Cell Adhesion Molecule-1
Fibroblasts
Advanced Glycosylation End Products
Amyloidosis
Northern Blotting
Arthritis
Dialysis
Blood Cells
Flow Cytometry
Joints
Western Blotting
Immunohistochemistry
Messenger RNA
Proteins

Keywords

  • Advanced glycation end products
  • Amyloidosis
  • Articular disease
  • Dialysis amyloid
  • Hemodialysis

ASJC Scopus subject areas

  • Nephrology

Cite this

β2-Microglobulin increases the expression of vascular cell adhesion molecule on human synovial fibroblasts. / Jaradat, M. I.; Schnizlein-Bick, C. T.; Singh, G. K.; Moe, Sharon.

In: Kidney International, Vol. 59, No. 5, 2001, p. 1951-1959.

Research output: Contribution to journalArticle

Jaradat, M. I. ; Schnizlein-Bick, C. T. ; Singh, G. K. ; Moe, Sharon. / β2-Microglobulin increases the expression of vascular cell adhesion molecule on human synovial fibroblasts. In: Kidney International. 2001 ; Vol. 59, No. 5. pp. 1951-1959.
@article{8e9a4af25e9946e2a943926a4fada889,
title = "β2-Microglobulin increases the expression of vascular cell adhesion molecule on human synovial fibroblasts",
abstract = "Background. β2-Microglobulin (β2m) amyloidosis is a destructive articular disease that affects patients on dialysis. The disease presentation is similar to other forms of arthritis in which adhesion molecules are felt to be pathogenic. Therefore, we hypothesized that β2m directly increases the expression of vascular cell adhesion molecule-1 (VCAM-1) by synovial fibroblasts. We also examined the effect of alteration of β2m by advanced glycation end products on this cellular response. Methods. Human synovial fibroblasts were isolated and incubated with β2m with and without alteration with advanced glycation end products. VCAM-1 expression was determined by immunohistochemistry, flow cytometry, and Western blot and Northern blot analyses. Results. β2m increased the protein expression of VCAM-1 by synovial fibroblasts in a dose-dependent manner. β2m altered with advanced glycation end products had no effect. However, all forms of β2m increased VCAM-1 mRNA. β2m also increased the adhesion of peripheral blood mononuclear cells to synovial fibroblasts. Conclusion. β2m directly increases the expression of VCAM-1 by synovial fibroblasts, indicating that synovial fibroblasts may play a key role in the pathogenesis of β2m amyloidosis.",
keywords = "Advanced glycation end products, Amyloidosis, Articular disease, Dialysis amyloid, Hemodialysis",
author = "Jaradat, {M. I.} and Schnizlein-Bick, {C. T.} and Singh, {G. K.} and Sharon Moe",
year = "2001",
doi = "10.1046/j.1523-1755.2001.0590051951.x",
language = "English",
volume = "59",
pages = "1951--1959",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - β2-Microglobulin increases the expression of vascular cell adhesion molecule on human synovial fibroblasts

AU - Jaradat, M. I.

AU - Schnizlein-Bick, C. T.

AU - Singh, G. K.

AU - Moe, Sharon

PY - 2001

Y1 - 2001

N2 - Background. β2-Microglobulin (β2m) amyloidosis is a destructive articular disease that affects patients on dialysis. The disease presentation is similar to other forms of arthritis in which adhesion molecules are felt to be pathogenic. Therefore, we hypothesized that β2m directly increases the expression of vascular cell adhesion molecule-1 (VCAM-1) by synovial fibroblasts. We also examined the effect of alteration of β2m by advanced glycation end products on this cellular response. Methods. Human synovial fibroblasts were isolated and incubated with β2m with and without alteration with advanced glycation end products. VCAM-1 expression was determined by immunohistochemistry, flow cytometry, and Western blot and Northern blot analyses. Results. β2m increased the protein expression of VCAM-1 by synovial fibroblasts in a dose-dependent manner. β2m altered with advanced glycation end products had no effect. However, all forms of β2m increased VCAM-1 mRNA. β2m also increased the adhesion of peripheral blood mononuclear cells to synovial fibroblasts. Conclusion. β2m directly increases the expression of VCAM-1 by synovial fibroblasts, indicating that synovial fibroblasts may play a key role in the pathogenesis of β2m amyloidosis.

AB - Background. β2-Microglobulin (β2m) amyloidosis is a destructive articular disease that affects patients on dialysis. The disease presentation is similar to other forms of arthritis in which adhesion molecules are felt to be pathogenic. Therefore, we hypothesized that β2m directly increases the expression of vascular cell adhesion molecule-1 (VCAM-1) by synovial fibroblasts. We also examined the effect of alteration of β2m by advanced glycation end products on this cellular response. Methods. Human synovial fibroblasts were isolated and incubated with β2m with and without alteration with advanced glycation end products. VCAM-1 expression was determined by immunohistochemistry, flow cytometry, and Western blot and Northern blot analyses. Results. β2m increased the protein expression of VCAM-1 by synovial fibroblasts in a dose-dependent manner. β2m altered with advanced glycation end products had no effect. However, all forms of β2m increased VCAM-1 mRNA. β2m also increased the adhesion of peripheral blood mononuclear cells to synovial fibroblasts. Conclusion. β2m directly increases the expression of VCAM-1 by synovial fibroblasts, indicating that synovial fibroblasts may play a key role in the pathogenesis of β2m amyloidosis.

KW - Advanced glycation end products

KW - Amyloidosis

KW - Articular disease

KW - Dialysis amyloid

KW - Hemodialysis

UR - http://www.scopus.com/inward/record.url?scp=0035049541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035049541&partnerID=8YFLogxK

U2 - 10.1046/j.1523-1755.2001.0590051951.x

DO - 10.1046/j.1523-1755.2001.0590051951.x

M3 - Article

C2 - 11318968

AN - SCOPUS:0035049541

VL - 59

SP - 1951

EP - 1959

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -